A Clinical Study of JS105 in Combination With Other Anti-tumor Therapies in Patients With Solid Tumors

JS105 is administered once daily, orally

Fulvestrant intramuscularly,The first cycle was injected once in D1 and D15, and then once in each cycle D1, and 28 days was 1 cycle

Dalpiciclib Isetionate Tablets, QD, oral, taken continuously for 21 days, then stopped for 7 days, 28 days for a cycle

Toripalimab Injection,Intravenous infusion, once every 3 weeks, 21 days for 1 cycle

Paclitaxel for Injection (Albumin Bound),Intravenous infusion, D1, 8, 15 infusion, every 28 days for a cycle

Fluzoparib Capsules is administered once daily, orally

Pyrotinib Maleate Tablets is administered once daily, orally

Capecitabine Tablets is administered once daily, orally